🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04922892
Recruiting Not applicable

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

NCT04922892 · tracked via the Priya Life Science China tracker
Sponsor
The Second Hospital of Nanjing Medical University
Phase
Not applicable
Started
2021-06-01
Last updated
2021-09-27

Condition(s) studied

Secondary Hyperparathyroidism;Parathyroidectomy

Investigational drug(s) / intervention(s)

Parathyroidectomy

Parathyroidectomy: Total Parathyroidectomy With Autotransplantation or Total Parathyroidectomy Alone

Study summary

Total parathyroidectomy with autotransplantation (TPTX+AT) and Total parathyr- oidectomy alone (TPTX) are the common surgical procedures.The purpose of the study was to compare the long-term benefits of surgery between the two groups.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: Severe renal secondary hyperparathyroidism Exclusion Criteria: Patients with diabetes a history of chronic inflammatory disease a history of malignant tumor a history of kidney transplantation a history of neck surgery a history of alcohol abuse a history of drug abuse inability to cooperate with the participants refusal to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
NanjingMU Nanjing China Recruiting

More The Second Hospital of Nanjing Medical University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04922892 on ClinicalTrials.gov ↗ ← All trials in China